Ridgefield, CT, United States of America

Nelamangala Nagaraja

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Nelamangala Nagaraja: Innovator in Biopharmaceuticals

Introduction

Nelamangala Nagaraja is a prominent inventor based in Ridgefield, CT (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of compounds targeting specific inflammatory pathways. With a total of 3 patents to his name, Nagaraja's work is paving the way for innovative treatments.

Latest Patents

Nagaraja's latest patents include a compound targeting IL-23A and TNF-alpha, which focuses on the development of compounds specific for these targets. The disclosure relates to compositions comprising these compounds and methods of use thereof. Additionally, nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed, showcasing the depth of his research.

Career Highlights

Throughout his career, Nagaraja has worked with notable companies in the biopharmaceutical industry. He has been associated with Boehringer Ingelheim International GmbH and Macrogenics, Inc., where he has contributed to various innovative projects. His expertise in the field has allowed him to make impactful advancements in therapeutic development.

Collaborations

Nagaraja has collaborated with several professionals in his field, including Rachel Rebecca Barrett and Leslie Sydnor Johnson. These collaborations have further enhanced his research and development efforts, leading to significant advancements in biopharmaceutical innovations.

Conclusion

Nelamangala Nagaraja is a distinguished inventor whose work in targeting IL-23A and TNF-alpha is making waves in the biopharmaceutical industry. His contributions and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…